BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
570 results:

  • 1. Development, synthesis and validation of improved c-Myc/max inhibitors.
    Yıldırım S; Kocabaş F; Mermer A
    J Cell Mol Med; 2024 Apr; 28(8):e18272. PubMed ID: 38568057
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison of clinical efficacy and safety between robotic-assisted and laparoscopic adrenalectomy for pheochromocytoma: a systematic review and meta-analysis.
    Wang L; Zeng W; Wu Y; Gong Z
    J Robot Surg; 2024 Mar; 18(1):115. PubMed ID: 38466492
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Updates on the genetics of multiple endocrine neoplasia.
    Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
    Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EUS-guided tissue acquisition in patients with solid pseudopapillary neoplasms of the pancreas.
    Jiménez-Gutiérrez JM; de la Mora-Levy JG; Alonso-Lárraga JO; Hernández-Guerrero AI; Soriano-Herrera BA; Villegas-González LF; Uscanga-Domínguez LF; López-Romero S; Téllez-Ávila FI
    Postgrad Med; 2024 Jan; 136(1):78-83. PubMed ID: 38315145
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Potential Added Value of
    Chen S; Wang G; Wu L; Chen D; Fang K; Liu W; Xu B; Zhai YQ; Li M
    BMC Gastroenterol; 2024 Jan; 24(1):37. PubMed ID: 38233765
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
    J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunohistochemical FAP Expression Reflects
    Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
    J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prediction of
    Mileva M; Marin G; Levillain H; Artigas C; Van Bogaert C; Marin C; Danieli R; Deleporte A; Picchia S; Stathopoulos K; Jungels C; Vanderlinden B; Paesmans M; Ameye L; Critchi G; Taraji-Schiltz L; Velghe C; Wimana Z; Bali M; Hendlisz A; Flamen P; Karfis I
    J Nucl Med; 2024 Feb; 65(2):236-244. PubMed ID: 38164576
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
    Seckinger A; Majocchi S; Moine V; Nouveau L; Ngoc H; Daubeuf B; Ravn U; Pleche N; Calloud S; Broyer L; Cons L; Lesnier A; Chatel L; Papaioannou A; Salgado-Pires S; Krämer S; Gockel I; Lordick F; Masternak K; Poitevin Y; Magistrelli G; Malinge P; Shang L; Kallendrusch S; Strein K; Hose D
    J Hematol Oncol; 2023 Dec; 16(1):117. PubMed ID: 38087365
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genotype-phenotype correlations in paediatric and adolescent phaeochromocytoma and paraganglioma: a cross-sectional study.
    Seabrook A; Vasudevan A; Neville K; Gerstl B; Benn D; Smith J; Kirk J; Gill A; Clifton-Bligh R; Tucker K
    Arch Dis Child; 2024 Feb; 109(3):201-208. PubMed ID: 38071512
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Kessler L; Hirmas N; Pabst KM; Hamacher R; Ferdinandus J; Schaarschmidt BM; Milosevic A; Nader M; Umutlu L; Uhl W; Reinacher-Schick A; Lugnier C; Witte D; Niedergethmann M; Herrmann K; Fendler WP; Siveke JT
    J Nucl Med; 2023 Dec; 64(12):1910-1917. PubMed ID: 37973185
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnostic Performance of Thyroid Nodule Risk Stratification Systems: Comparison of ACR-TIRADS, EU-TIRADS, K-TIRADS, and ATA Guidelines.
    Yucel S; Balci IG; Tomak L
    Ultrasound Q; 2023 Dec; 39(4):206-211. PubMed ID: 37918114
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effect of Aprepitant on Etoposide Pharmacokinetics in Patients with Testicular cancer: A Pharmacokinetic Study to Determine the Absence of a Clinically Relevant Interaction.
    Strik J; de Jong LAW; Sijm J; Desar IME; van Erp NP
    Clin Pharmacol Ther; 2024 Jan; 115(1):135-138. PubMed ID: 37867292
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with
    Watabe T; Kabayama K; Naka S; Yamamoto R; Kaneda K; Serada S; Ooe K; Toyoshima A; Wang Y; Haba H; Kurimoto K; Kobayashi T; Shimosegawa E; Tomiyama N; Fukase K; Naka T
    J Nucl Med; 2023 Dec; 64(12):1949-1955. PubMed ID: 37827841
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer.
    Khojasteh-Leylakoohi F; Mohit R; Khalili-Tanha N; Asadnia A; Naderi H; Pourali G; Yousefli Z; Khalili-Tanha G; Khazaei M; Maftooh M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Shahidsales S; Lam AK; Giovannetti E; Nazari E; Batra J; Avan A
    Sci Rep; 2023 Oct; 13(1):16678. PubMed ID: 37794108
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Methylation-Mediated Silencing of ATF3 Promotes Thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
    Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
    Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
    [No Abstract]    [Full Text] [Related]  

  • 17. Clinical application of Al
    Lyu Z; Han W; Zhang Q; Zhao H; Liu S; Wang Y; He J; Zhao C; Tian L; Fu P
    Cancer Imaging; 2023 Sep; 23(1):86. PubMed ID: 37700343
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical value of grayscale ultrasound combined with real-time shear wave elastography nomogram in risk prediction of thyroid cancer.
    Ren T; Jiang M; Wu J; Zhang F; Zhang C
    BMC Med Imaging; 2023 Sep; 23(1):123. PubMed ID: 37700270
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Digital analyses of nuclear features can help discriminate among non-invasive follicular thyroid neoplasm with papillary-like nuclear features, papillary thyroid carcinoma follicular subtype, and follicular carcinoma in cytological specimens.
    Yamamoto FM; Liano LC; Camilo-Júnior DJ; Xavier-Junior JCC
    Cytopathology; 2024 Jan; 35(1):98-104. PubMed ID: 37688777
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer.
    Hoffman SLV; Mixdorf JC; Kwon O; Johnson TR; Makvandi M; Lee H; Aluicio-Sarduy E; Barnhart TE; Jeffery JJ; Patankar MS; Engle JW; Bednarz BP; Ellison PA
    Nucl Med Biol; 2023; 122-123():108368. PubMed ID: 37490805
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 29.